Introduction HIV-associated lymphomas are predominantly aggressive B-cell lymphomas. According to the World Health Organization (WHO) classification, HIV-associated systemic non-Hodgkin’s lymphomas (HIV-NHLs) include diffuse large B-cell lymphoma (DLBCL), HIV-associated primary central nervous system lymphoma (HIV-PCNSL), Burkitt lymphoma (BL), primary effusion lymphoma (PEL) and plasmablastic lymphoma of the oral cavity. Hodgkin disease, though not an AIDS-defining condition, […]
MBChB, MRCP(UK), FHKAM(Medicine)
Dr MAK is an Associate Consultant of the Department of Medicine, Queen Elizabeth Hospital (QEH), Hong Kong. She is a medical oncologist, and a member of the Clinical AIDS Service of QEH. She works to ensure that HIV patients with malignancy have optimal cancer care.
Introduction Worldwide, cancer is the third leading cause of death. Evolving demographic shift leads to the projection that cancer cases and deaths will double globally over the next 20-40 years. HIV infection poses an increased risk of cancers, the cause of which is multifactorial. HIV-associated immunosuppression compromises the ability to mount an immune response against […]